HUCOG 2000 HP Injection contains Human Chorionic Gonadotropin (hCG) at a strength of 2000 IU per dose. It is a gonadotropin hormone used primarily in the treatment of infertility and certain hormonal deficiencies. HUCOG 2000 HP acts by mimicking the luteinizing hormone (LH) surge, thereby stimulating ovulation in females and promoting testosterone production in males. In women, it is indicated for the induction of ovulation and pregnancy in anovulatory or oligo-ovulatory patients undergoing assisted reproductive techniques such as intrauterine insemination (IUI) or in vitro fertilization (IVF). In males, it is used to treat hypogonadotropic hypogonadism by stimulating Leydig cells to produce testosterone, which is essential for spermatogenesis and secondary sexual characteristics. The injection is administered intramuscularly or subcutaneously as per the prescribing physician’s guidance. Dosage and duration depend on the specific clinical indication and patient response. HUCOG 2000 HP should be used under strict medical supervision due to potential side effects such as ovarian hyperstimulation syndrome (OHSS), allergic reactions, or injection site discomfort. It is contraindicated in patients with hormone-sensitive tumors or hypersensitivity to hCG. Proper patient evaluation and monitoring are essential to ensure safe and effective therapy.